Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases

BACKGROUND: Despite the increased use of rituximab in treating pediatric patients with autoimmune diseases in the last decade, there are limited data on rituximab safety in those subjects who have a developing immune system. The objective of this study is to determine the prevalence of hypogammaglob...

Descripción completa

Detalles Bibliográficos
Autores principales: Khojah, Amer M., Miller, Michael L., Klein-Gitelman, Marisa S., Curran, Megan L., Hans, Victoria, Pachman, Lauren M., Fuleihan, Ramsay L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712749/
https://www.ncbi.nlm.nih.gov/pubmed/31462263
http://dx.doi.org/10.1186/s12969-019-0365-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712749/
https://www.ncbi.nlm.nih.gov/pubmed/31462263
http://dx.doi.org/10.1186/s12969-019-0365-y

Ejemplares similares